C-CAMP, in partnership with the Netherlands Embassy and Invest in Holland, offers Indian health tech companies a catapult program to enter and expand in the Dutch health ecosystem.
Create a free account and we'll tell you whether your startup qualifies for this grant.
Frequently Asked Questions
What kind of funding does this program provide?
The C-CAMP Netherlands Global Innovation Catapult is a market-access and soft-landing program, not a funding program. It does not provide any cash grants, investments, or repayable loans. Its value lies in facilitating market entry, providing regulatory guidance, and offering networking opportunities in the Dutch healthcare ecosystem.
Who is eligible to apply for this program?
Indian health tech companies that have reached a commercial stage (scaling up, revenue generating, or in active deployment/piloting phase) are eligible. Priority is given to technologies that reduce employee workload, enhance operational efficiency, expand care to non-hospital settings, promote patient self-sufficiency, or optimize tasks through automation. Companies with CE certification or a clear pathway to it will receive priority.
What are the key benefits for selected companies?
Selected companies will gain access to expert knowledge and regulatory support for the Dutch healthcare market, participate in a round table service with the Dutch Ministry of Health, Welfare and Sport (VWS), and receive facilitated introductions to key stakeholders in the Dutch healthcare sector by the Netherlands Foreign Investment Agency (NFIA). The program aims to enable partnerships, market validation, and expansion into the Netherlands and the broader EU.
Are travel and accommodation expenses covered?
No, participants are responsible for bearing their own travel and accommodation costs for the visit to the Netherlands. The program focuses on providing market access, knowledge, and networking support.
What is the deadline for applications?
The call for applications closes on July 5th, 2026. Interested companies should submit their Expression of Interest before this date.
What types of health technologies are in focus?
The program seeks technologies that reduce employee workload (e.g., automated vitals, AI diagnostics), enhance operational efficiency (e.g., smart wards, AI assistants), expand care to non-hospital settings (e.g., wearable biosensors, remote monitoring), promote patient self-sufficiency (e.g., portable heart monitoring, at-home rehab), and optimize tasks through automation (e.g., neonatal therapy, medicine dispensaries).
About this grant
This program is designed to bridge the gap between innovative Indian health tech startups and the thriving Dutch healthcare ecosystem.
C-CAMP, in collaboration with the Netherlands Embassy in India and Invest in Holland, has launched the Global Innovation Catapult to serve as a critical entry and expansion pathway for promising Indian companies. The initiative targets health technologies that can significantly benefit Dutch healthcare professionals and patients by addressing key needs such as reducing employee workload, enhancing operational efficiency, expanding care into non-hospital settings like homecare, promoting patient self-sufficiency, and optimizing tasks through automation to limit human intervention. Through this unique catapult program, C-CAMP and its partners aim to foster strategic international collaborations, enable market validation for Indian innovations, and facilitate significant market expansion for selected companies within the Netherlands and the broader European Union. This program is a testament to the commitment of both India and the Netherlands to drive global healthcare innovation through cross-border partnerships, offering a unique opportunity for Indian innovators to gain a foothold in a highly developed European market.
Eligibility
Indian health tech companies at a commercial stage (scaling up, revenue generating, or in active deployment/piloting) are invited to apply.
Priority is given to technologies that reduce employee workload, enhance operational efficiency, expand care to non-hospital settings, promote patient self-sufficiency, or optimize tasks through automation.
Companies with CE certification or a near-term certification pathway will receive preference.
Benefits & Funding
Equity-free (non-dilutive)
Non-repayable grant
Disbursed as grant
While this program does not offer direct cash grants or equity investments, it provides invaluable market access and comprehensive soft-landing support for Indian health tech innovators looking to enter the European market via the Netherlands.
Selected companies will receive expert knowledge and regulatory guidance specific to the Dutch healthcare landscape, including insights into market dynamics, regulatory pathways, and best practices.
